CDKN2A and acute lymphoblastic leukemia: Duy et al. reported that the growth of TKI-resistant Ph+ acute lymphoblastic leukemia (Ph+ ALL) cells was related to Bcl-6 activity and the pathogenesis of ALL was closely associated with the Bcl-6/Arf/p53 pathway signals [28].